Recommendations for a brief international cognitive assessment for multiple sclerosis (BICAMS) DW Langdon, MP Amato, J Boringa, B Brochet, F Foley, S Fredrikson, ... Multiple Sclerosis Journal 18 (6), 891-898, 2012 | 935 | 2012 |
Minimal neuropsychological assessment of MS patients: a consensus approach RHB Benedict, JS Fischer, CJ Archibald, PA Arnett, WW Beatty, J Bobholz, ... The Clinical Neuropsychologist 16 (3), 381-397, 2002 | 818 | 2002 |
Cognition in multiple sclerosis DW Langdon Current opinion in neurology 24 (3), 244-249, 2011 | 523 | 2011 |
Brief International Cognitive Assessment for MS (BICAMS): international standards for validation RHB Benedict, MP Amato, J Boringa, B Brochet, F Foley, S Fredrikson, ... BMC neurology 12, 1-7, 2012 | 441 | 2012 |
Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility loci NA Patsopoulos, ... Annals of neurology 70 (6), 897-912, 2011 | 363 | 2011 |
Evidence-based measurement: which disability scale for neurologic rehabilitation? JC Hobart, DL Lamping, JA Freeman, DW Langdon, DL McLellan, ... Neurology 57 (4), 639-644, 2001 | 340 | 2001 |
Neurological physiotherapy: a problem-solving approach S Edwards (No Title), 2002 | 333 | 2002 |
Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates SJ Camp, VL Stevenson, AJ Thompson, DH Miller, C Borras, ... Brain 122 (7), 1341-1348, 1999 | 325 | 1999 |
The impact of inpatient rehabilitation on progressive multiple sclerosis JA Freeman, DW Langdon, JC Hobart, AJ Thompson Annals of Neurology: Official Journal of the American Neurological …, 1997 | 325 | 1997 |
Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial DS Goodin, AT Reder, GC Ebers, G Cutter, M Kremenchutzky, J Oger, ... Neurology 78 (17), 1315-1322, 2012 | 315 | 2012 |
Executive function and language in deaf children B Figueras, L Edwards, D Langdon Journal of deaf studies and deaf education 13 (3), 362-377, 2008 | 298 | 2008 |
Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score PL De Jager, LB Chibnik, J Cui, J Reischl, S Lehr, KC Simon, C Aubin, ... The Lancet Neurology 8 (12), 1111-1119, 2009 | 293 | 2009 |
Treatment of cognitive impairment in multiple sclerosis: position paper MP Amato, D Langdon, X Montalban, RHB Benedict, J DeLuca, LB Krupp, ... Journal of neurology 260, 1452-1468, 2013 | 282 | 2013 |
Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community? JA Freeman, DW Langdon, JC Hobart, AJ Thompson Neurology 52 (1), 50-50, 1999 | 216 | 1999 |
Cerebellar contributions to working memory AL Hayter, DW Langdon, N Ramnani Neuroimage 36 (3), 943-954, 2007 | 180 | 2007 |
Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome DW Langdon, AJ Thompson Multiple Sclerosis Journal 5 (2), 94-100, 1999 | 177 | 1999 |
Cognitive impairment among patients with multiple sclerosis: associations with employment and quality of life J Campbell, W Rashid, M Cercignani, D Langdon Postgraduate medical journal 93 (1097), 143-147, 2017 | 168 | 2017 |
Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis JA Freeman, JC Hobart, DW Langdon, AJ Thompson Journal of Neurology, Neurosurgery & Psychiatry 68 (2), 150-156, 2000 | 166 | 2000 |
Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial GC Ebers, A Traboulsee, D Li, D Langdon, AT Reder, DS Goodin, ... Journal of Neurology, Neurosurgery & Psychiatry 81 (8), 907-912, 2010 | 163 | 2010 |
High-intensity interval exercise improves cognitive performance and reduces matrix metalloproteinases-2 serum levels in persons with multiple sclerosis: A randomized controlled … P Zimmer, W Bloch, A Schenk, M Oberste, S Riedel, J Kool, D Langdon, ... Multiple Sclerosis Journal 24 (12), 1635-1644, 2018 | 150 | 2018 |